Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 5/20 | 0.38 |
| ▸ | PTGDR | Q13258 | 3/20 | 0.38 |
| ▸ | PPARG | P37231 | 6/20 | 0.38 |
| ▸ | HTR6 | P50406 | 4/20 | 0.36 |
| ▸ | PPARA | Q07869 | 5/20 | 0.36 |
| ▸ | ICMT | O60725 | 2/20 | 0.35 |
| ▸ | PPARD | Q03181 | 3/20 | 0.34 |
| ▸ | RORC | P51449 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL7313830 | 0.90 | PTGDR (0.45) | PTGDR2PTGDRPPARGHTR6PPARA | |
| Trifluoroacetic Acid SCHEMBL7307842 | 0.81 | PTGDR (0.43) | PTGDR2PTGDRPPARGHTR6PPARA | |
| Trifluoroacetic Acid SCHEMBL7583561 | 0.72 | ICMT (0.37) | PTGDR2PTGDRHTR6ICMT | |
| Trifluoroacetic Acid SCHEMBL7320899 | 0.72 | SERPINE1 (0.33) | PTGDR2PPARGHTR6 | |
| Trifluoroacetic Acid SCHEMBL7405232 | 0.72 | PTGS2 (0.34) | PTGDR2 | |
| Trifluoroacetic Acid SCHEMBL7318370 | 0.70 | HTR6 (0.49) | PPARGHTR6PPARAPPARD | |
| Oxalic Acid SCHEMBL7448579 | 0.65 | HTR6 (0.71) | PTGDR2PTGDRHTR6 | |
| Trifluoroacetic Acid SCHEMBL7315970 | 0.64 | CCR2 (0.41) | — | |
| Trifluoroacetic Acid SCHEMBL7316949 | 0.64 | ABCB11 (0.40) | — | |
| Trifluoroacetic Acid SCHEMBL7307478 | 0.64 | ICMT (0.52) | ICMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010007877-A1 | NOVEL ANTI-INFECTIVES | SMITHKLINE BEECHAM CORPORATION | 2001-07-12 | — | — | US | claimed |
| US-20020004198-A1 | Novel anti-infectives | SMITHKLINE BEECHAM CORPORATION | 2002-01-10 | — | — | US | disclosed |
| US-20010007877-A1 | NOVEL ANTI-INFECTIVES | SMITHKLINE BEECHAM CORPORATION | 2001-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010007877-A1 | NOVEL ANTI-INFECTIVES | CTSL, MMP8, SERPINB1 | PTGDR2 4010/4885PTGDR 4250/4885PPARG 2889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.